Home › Funds › NAN FUNG TRINITY (HK) Ltd › BCAX

NAN FUNG TRINITY (HK) Ltd position in BCAX

BICARA THERAPEUTICS INC · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 427,885 shares of BCAX (BICARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 0.76% of its reported portfolio and ranking #44 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed BCAX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)427.88K sh
Reported value held$7.96M
Portfolio Weight0.76%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's BCAX position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in BCAX in Q2 2025 at 342,885 shares (US$3.2M). The position peaked in Q2 2026 at 427,885 shares, worth US$12.7M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 427,885 shares valued at US$8.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 342.88K $3.19M New
Q3 2025 384.88K $6.08M Add
Q4 2025 372.38K $6.27M Reduce
Q1 2026 427.88K $8.51M Add
Q2 2026 427.88K $12.70M Hold
Q3 2026 427.88K $7.96M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held BCAX?

NAN FUNG TRINITY (HK) Ltd has disclosed BCAX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in BCAX?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 427.88K shares of BCAX (BICARA THERAPEUTICS INC), valued at $7.96M, representing 0.76% of its reported portfolio and ranking #44.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling BCAX?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in BCAX. The position peaked in Q2 2026 at 427.88K shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Deep Track Capital, LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.